SCYNEXIS Data Presentations at ECCMID 2018 Show SCY-078 Potent and Synergistic Antifungal Activity Against Aspergillus and Pneumocystis

Published study further demonstrates in vitro activity of SCY-078 against Aspergillus strains when used alone or in combination Clinical efficacy against Aspergillus strains to be tested in Phase 2 trial to begin in third quarter of 2018 Antifungal activity against Pneumocystis supports potential


Leave a Reply

Your email address will not be published.